FY21 Results: Not a lot of new news from SSM today given financial metrics were well know given recent capital raise, one aspect that I thought was bullish was EBITDA guidance for FY22 of ~$120m including around ~$17m in synergies, we were expecting SSM to be on a run rate for the upcoming year closer to $100m. No dividend for the half given their use of funds for their recent acquisition however that was expected. We’ll need to do some more work on SSM however there were no negative surprises to MM in today’s result. The stock ended 2.82% lower.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Pulse Check Webinar: Discover the stocks to own as rates fall
Close
Friday 11th October – ASX down 9pts – quiet day!
Close
Australian Super Asset Allocation – Balanced Option
Close
Market Matters Video Update – Portfolio Performance & Positioning for August 2024 with Shawn & James
Close
Friday 11th October – Dow down -57pts, SPI off -3pts
Close
MM remains a holder of SSM in the income
Add To Hit List
Related Q&A
Thoughts on SSM & SFR, please
Thoughts on Emeco (EHL) & Service Stream (SSM) please
What’s MM thoughts on SSM from here?
Is SSM the great dividend stock it would appear?
What is MM’s yield estimate for SSM?
What to do with Service Stream (SSM)?
Service Stream (SSM)
What to do with Service Stream (SSM)?
Service Stream (SSM)
Relevant suggested news and content from the site
Video
WATCH
Pulse Check Webinar: Discover the stocks to own as rates fall
Recorded Thursday 26th September
Podcast
LISTEN
Friday 11th October – ASX down 9pts – quiet day!
Daily Podcast Direct from the Desk
chart
Australian Super Asset Allocation – Balanced Option
Video
WATCH
Market Matters Video Update – Portfolio Performance & Positioning for August 2024 with Shawn & James
Recorded 10-9-24
Podcast
LISTEN
Friday 11th October – Dow down -57pts, SPI off -3pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.